Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks .

Recent Articles

Nokia Is on Track to Renew Its Dividends

By Mark R. Hake, CFA Aug 5, 2020

Nokia is clearly free cash flow positive and on track to pay dividends. Nokia's FCF growth increases the likelihood of renewed quarterly dividends and could push Nokia stock higher.

Royal Caribbean Stock’s Dead Money Without a Widely Available Vaccine

By Mark R. Hake, CFA Aug 5, 2020

Royal Caribbean will languish until a vaccine is widely available. RCL is likely to fall at least 8% over the next year, given the company's liquidity level and cash burn rate.

MGM Resorts May Have Just Enough Liquidity to Survive

By Mark R. Hake, CFA Aug 4, 2020

MGM stock is worth 3.5 times more, but because its liquidity is so tight right now, the road to those gains will be rocky.

Carnival Stock Has Smooth Seas in Its Future

By Mark R. Hake, CFA Aug 4, 2020

Carnival is struggling, but it will do well in the long run. Expect CCL stock to soar to three or four times its current price.

Bristol-Myers Squibb Has Great Potential Ahead of Earnings

By Mark R. Hake, CFA Aug 4, 2020

Ahead earnings, Bristol-Myers Squibb is a great value play. In fact, BMY stock is worth 30%-70% more than its current share price.